(S)-N-(2-Oxotetrahydrofuran-3-yl)palmitamide

Catalog No. :
ACYHEZ308
CAS No. :
87206-01-7
Molecular Formula :
C20H37NO3
Molecular Weight :
339.52

IUPAC Name:(S)-N-(2-oxotetrahydrofuran-3-yl)palmitamide

(S)-N-(2-Oxotetrahydrofuran-3-yl)palmitamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$286.00Login to see priceInquiryInquiry
50mg95%$509.00Login to see priceInquiryInquiry
100mg95%$829.00Login to see priceInquiryInquiry
250mg95%$1462.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-N-(2-Oxotetrahydrofuran-3-yl)palmitamide
IUPAC Name(S)-N-(2-oxotetrahydrofuran-3-yl)palmitamide
MDL No.MFCD18382092
Molecular FormulaC20H37NO3
Molecular Weight339.52
SMILESCCCCCCCCCCCCCCCC(N[C@@H]1C(OCC1)=O)=O
InChI KeyQJIXVOQAEZMUIH-SFHVURJKSA-N
SynonymN-palmitoyl-L-Homoserine | N-hexadecanoyl-L-Homoserine lactone | C16-HSL | (S)-N-(2-oxotetrahydrofuran-3-yl)palmitamide
CAS No.87206-01-7
PubChem CID11609787

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYHEZ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKHRS769 route compound structure diagram
    ACKHRS7692601-98-1 In Stock
  2. Plus
  3. ACSIZK961 route compound structure diagram
    ACSIZK96115295-77-9 In Stock
  4. Then
  5. ACYHEZ308 route product structure diagram
    ACYHEZ30887206-01-7
Inquiry

2. ACYHEZ308 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSIZK961 route compound structure diagram
    ACSIZK96115295-77-9 In Stock
  4. Then
  5. ACYHEZ308 route product structure diagram
    ACYHEZ30887206-01-7
Inquiry

Comments (0)